Alignment Healthcare, Inc. ALHC
We take great care to ensure that the data presented and summarized in this overview for Alignment Healthcare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ALHC
View all-
General Atlantic LLC New York, NY61MShares$804 Million24.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$129 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.65MShares$114 Million0.06% of portfolio
-
Black Rock Inc. New York, NY8.19MShares$108 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.44MShares$98 Million0.02% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY7.3MShares$96.3 Million2.03% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL4.95MShares$65.3 Million0.96% of portfolio
-
Durable Capital Partners LP Bethesda, MD4.59MShares$60.4 Million0.45% of portfolio
-
8 Knots Management, LLC Dallas, TX3.66MShares$48.2 Million4.65% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.39MShares$44.7 Million0.02% of portfolio
Latest Institutional Activity in ALHC
Top Purchases
Top Sells
About ALHC
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Insider Transactions at ALHC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.87%
|
$390,000
$13.72 P/Share
|
Feb 12
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
14,878
-6.9%
|
$208,292
$14.38 P/Share
|
Feb 11
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.96%
|
$1,260,000
$14.23 P/Share
|
Jan 24
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
14,500
-4.68%
|
$203,000
$14.98 P/Share
|
Jan 21
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
10,500
-3.28%
|
$147,000
$14.99 P/Share
|
Jan 15
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.83%
|
$390,000
$13.61 P/Share
|
Jan 13
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-1.92%
|
$1,170,000
$13.11 P/Share
|
Dec 16
2024
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.8%
|
$330,000
$11.33 P/Share
|
Dec 11
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.67%
|
$990,000
$11.65 P/Share
|
Dec 10
2024
|
Sebastian Burzacchi COO - Mgmt Services Org |
SELL
Open market or private sale
|
Direct |
8,550
-3.78%
|
$94,050
$11.26 P/Share
|
Dec 05
2024
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
62,574
-11.74%
|
$750,888
$12.2 P/Share
|
Nov 27
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
35,000
-9.85%
|
$420,000
$12.8 P/Share
|
Nov 22
2024
|
Dawn Christine Maroney President |
SELL
Bona fide gift
|
Direct |
30,000
-1.77%
|
-
|
Nov 15
2024
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.74%
|
$330,000
$11.35 P/Share
|
Nov 11
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
30,500
-24.71%
|
$396,500
$13.42 P/Share
|
Nov 11
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
6,920
-0.61%
|
$89,960
$13.73 P/Share
|
Nov 11
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.54%
|
$1,170,000
$13.42 P/Share
|
Nov 04
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
20,500
-5.45%
|
$266,500
$13.06 P/Share
|
Nov 01
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,500
-1.18%
|
$54,000
$12.98 P/Share
|
Oct 31
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
36,197
-22.68%
|
$434,364
$12.04 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 2.09M shares |
---|---|
Open market or private purchase | 103K shares |
Open market or private sale | 1.98M shares |
---|---|
Payment of exercise price or tax liability | 34.5K shares |
Bona fide gift | 36K shares |